DOI: 10.1055/s-00035331

Revista Urología Colombiana / Colombian Urology Journal

References

Fizazi K, Scher HI, Molina A. , et al; COU-AA-301 Investigators.
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.

Lancet Oncol 2012;
13 (10) 983-992

Fizazi K, Scher HI, Molina A. , et al; COU-AA-301 Investigators.
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.

Lancet Oncol 2012;
13 (10) 983-992

Download Bibliographical Data

Search in:
Access: